UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 99 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $316,000 | +72.7% | 52,683 | +50.5% | 0.00% | – |
| Q4 2020 | $183,000 | +51.2% | 35,000 | 0.0% | 0.00% | – |
| Q3 2020 | $121,000 | -75.6% | 35,000 | -38.7% | 0.00% | – |
| Q2 2020 | $496,000 | +77.8% | 57,142 | +18.7% | 0.00% | – |
| Q1 2020 | $279,000 | -6.4% | 48,142 | +16.4% | 0.00% | – |
| Q4 2019 | $298,000 | +18.3% | 41,342 | 0.0% | 0.00% | – |
| Q3 2019 | $252,000 | -23.2% | 41,342 | +19.7% | 0.00% | – |
| Q2 2019 | $328,000 | +43.9% | 34,542 | +22.7% | 0.00% | – |
| Q1 2019 | $228,000 | +1.3% | 28,142 | +103.3% | 0.00% | – |
| Q4 2018 | $225,000 | – | 13,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
| Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
| Leap Investments LP | 13,400 | $78,000 | 0.11% |
| Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
| Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
| Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
| Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
| SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
| Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |